News Image

In a market where value is scarce, NASDAQ:LNTH offers a refreshing opportunity with its solid fundamentals.

By Mill Chart

Last update: Mar 21, 2024

Our stock screening tool has identified LANTHEUS HOLDINGS INC (NASDAQ:LNTH) as an undervalued gem with strong fundamentals. NASDAQ:LNTH boasts decent financial health and profitability while maintaining an attractive price point. We'll break it down further.

Understanding NASDAQ:LNTH's Valuation

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:LNTH has achieved a 8 out of 10:

  • The Price/Earnings ratio is 9.50, which indicates a very decent valuation of LNTH.
  • Based on the Price/Earnings ratio, LNTH is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.01. LNTH is valued rather cheaply when compared to this.
  • LNTH is valuated reasonably with a Price/Forward Earnings ratio of 8.83.
  • Based on the Price/Forward Earnings ratio, LNTH is valued cheaply inside the industry as 98.47% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, LNTH is valued rather cheaply.
  • Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LNTH is valued cheaper than 92.86% of the companies in the same industry.
  • The decent profitability rating of LNTH may justify a higher PE ratio.

Profitability Assessment of NASDAQ:LNTH

ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:LNTH, the assigned 7 is a significant indicator of profitability:

  • LNTH's Return On Assets of 19.79% is amongst the best of the industry. LNTH outperforms 98.47% of its industry peers.
  • LNTH's Return On Equity of 40.04% is amongst the best of the industry. LNTH outperforms 99.49% of its industry peers.
  • With an excellent Return On Invested Capital value of 26.97%, LNTH belongs to the best of the industry, outperforming 99.49% of the companies in the same industry.
  • With an excellent Profit Margin value of 25.20%, LNTH belongs to the best of the industry, outperforming 96.94% of the companies in the same industry.
  • LNTH's Profit Margin has improved in the last couple of years.
  • The Operating Margin of LNTH (38.31%) is better than 99.49% of its industry peers.
  • In the last couple of years the Operating Margin of LNTH has grown nicely.
  • Looking at the Gross Margin, with a value of 63.71%, LNTH is in the better half of the industry, outperforming 65.31% of the companies in the same industry.

Understanding NASDAQ:LNTH's Health Score

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:LNTH has received a 8 out of 10:

  • An Altman-Z score of 5.46 indicates that LNTH is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.46, LNTH belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
  • LNTH has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as LNTH would need 2.64 years to pay back of all of its debts.
  • The Debt to FCF ratio of LNTH (2.64) is better than 88.78% of its industry peers.
  • A Current Ratio of 5.80 indicates that LNTH has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 5.80, LNTH is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • LNTH has a Quick Ratio of 5.45. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • LNTH has a better Quick ratio (5.45) than 80.10% of its industry peers.

Deciphering NASDAQ:LNTH's Growth Rating

ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:LNTH scores a 8 out of 10:

  • The Earnings Per Share has grown by an impressive 47.63% over the past year.
  • The Earnings Per Share has been growing by 45.36% on average over the past years. This is a very strong growth
  • Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 38.64%.
  • LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.43% yearly.
  • The Earnings Per Share is expected to grow by 15.43% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 10.10% on average over the next years. This is quite good.

More Decent Value stocks can be found in our Decent Value screener.

For an up to date full fundamental analysis you can check the fundamental report of LNTH

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/19/2024, 7:01:46 PM)

After market: 63.81 0 (0%)

63.81

+1.48 (+2.37%)

LNTH News

News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image2 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image3 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image8 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image9 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image9 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image18 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Image18 days ago - ChartmillNASDAQ:LNTH is showing good growth, while it is not too expensive.

Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more